Profund Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.22M	Buy	396,389 +39,727	+11%	+$154K	0.04%	297
2025 Q4	$1.46M	Buy	356,662 +195,207	+121%	+$967K	0.04%	270
2025 Q3	$788K	Buy	161,455 +84,429	+110%	+$443K	0.03%	381
2025 Q2	$390K	Sell	77,026 -46,098	-37%	-$226K	0.01%	554
2025 Q1	$651K	Buy	123,124 +8,238	+7%	+$60.1K	0.03%	402
2024 Q4	$777K	Sell	114,886 -17,925	-13%	-$121K	0.03%	351
2024 Q3	$875K	Buy	132,811 +58,040	+78%	+$416K	0.03%	357
2024 Q2	$561K	Sell	74,771 -52,385	-41%	-$457K	0.02%	467
2024 Q1	$1.27M	Sell	127,156 -35,469	-22%	-$395K	0.05%	298
2023 Q4	$1.6M	Sell	162,625 -21,610	-12%	-$154K	0.07%	225
2023 Q3	$1.41M	Buy	184,235 +124,621	+209%	+$1.24M	0.08%	206
2023 Q2	$445K	Sell	59,614 -11,610	-16%	-$81.2K	0.02%	548
2023 Q1	$475K	Buy	+71,224	New	+$565K	0.03%	516